Company Profile:
Please note that GRANULES INDIA LIMITED is an Indian company, not a Turkish company.
Here is the company introduction:
Company Type: Manufacturer
Granules India Limited is a leading Indian pharmaceutical company with a focus on manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company specializes in the development, manufacturing, and marketing of high-quality, cost-effective generic drugs. Granules operates multiple manufacturing facilities that are approved by various global regulatory agencies, including the US FDA, EDQM, and others, indicating its commitment to global quality standards and its capability to supply products to regulated markets worldwide. Their integrated business model allows them to offer a comprehensive portfolio of products across the pharmaceutical value chain.
Enterprise Products
Granules India Limited is an Indian pharmaceutical company that manufactures and sells a wide range of pharmaceutical products globally, including potentially in Turkey through its distribution network. They do not have manufacturing facilities in Turkey.
Their product portfolio includes:
Active Pharmaceutical Ingredients (APIs)
Pharmaceutical Formulation Intermediates (PFIs)
Finished Dosages (FDs) such as tablets, capsules, and oral suspensions
Key therapeutic areas and products often include:
Pain Management
Fever and Cold
Muscle Relaxants
Gastrointestinal
Anti-Allergics
Cardiovascular
Some of their prominent products or ingredients include:
Paracetamol (Acetaminophen)
Ibuprofen
Metformin
Guaifenesin
Naproxen
Ranitidine
Domperidone
Cetirizine